Unknown

Dataset Information

0

Complement inhibition promotes endogenous neurogenesis and sustained anti-inflammatory neuroprotection following reperfused stroke.


ABSTRACT: The restoration of blood-flow following cerebral ischemia incites a series of deleterious cascades that exacerbate neuronal injury. Pharmacologic inhibition of the C3a-receptor ameliorates cerebral injury by attenuating post-ischemic inflammation. Recent reports also implicate C3a in the modulation of tissue repair, suggesting that complement may influence both injury and recovery at later post-ischemic time-points.To evaluate the effect of C3a-receptor antagonism on post-ischemic neurogenesis and neurological outcome in the subacute period of stroke, transient focal cerebral ischemia was induced in adult male C57BL/6 mice treated with multiple regimens of a C3a receptor antagonist (C3aRA).Low-dose C3aRA administration during the acute phase of stroke promotes neuroblast proliferation in the subventricular zone at 7 days. Additionally, the C3a receptor is expressed on T-lymphocytes within the ischemic territory at 7 days, and this cellular infiltrate is abrogated by C3aRA administration. Finally, C3aRA treatment confers robust histologic and functional neuroprotection at this delayed time-point.Targeted complement inhibition through low-dose antagonism of the C3a receptor promotes post-ischemic neuroblast proliferation in the SVZ. Furthermore, C3aRA administration suppresses T-lymphocyte infiltration and improves delayed functional and histologic outcome following reperfused stroke. Post-ischemic complement activation may be pharmacologically manipulated to yield an effective therapy for stroke.

SUBMITTER: Ducruet AF 

PROVIDER: S-EPMC3383680 | BioStudies | 2012-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6457046 | BioStudies
2015-01-01 | S-EPMC4533015 | BioStudies
1000-01-01 | S-EPMC5325120 | BioStudies
2017-01-01 | S-EPMC5650706 | BioStudies
2007-01-01 | S-EPMC4896215 | BioStudies
1000-01-01 | S-EPMC3677481 | BioStudies
2020-05-19 | E-MTAB-8389 | ArrayExpress
2020-05-19 | E-MTAB-8388 | ArrayExpress
1000-01-01 | S-EPMC5474439 | BioStudies
2015-01-01 | S-EPMC6495224 | BioStudies